Lawsonia intracellularis in Horses

Quick Facts

🏥 Condition Name
Lawsonia intracellularis Infection
📋 Also Known As
Lawsonia intracellularis, Equine Proliferative Enteropathy, EPE
📂 Category
Infectious Diseases - Bacterial
📁 Subcategory
N/A
🐴 Affects
Small intestine (primarily ileum)
🏷️ Type
Infectious
⚠️ Severity
Moderate to Severe
💊 Treatable
Yes, with early intervention
🔄 Contagious
Yes, through fecal-oral transmission
🧬 Hereditary
No
🐴 Common In
Weanling and yearling horses (3-8 months most commonly)

Lawsonia intracellularis Overview

Lawsonia intracellularis infection, also known as equine proliferative enteropathy, is a bacterial disease affecting the gastrointestinal tract of young horses, caused by the obligate intracellular organism Lawsonia intracellularis. This bacterium invades and proliferates within the cells lining the small intestine, particularly the ileum, causing thickening of the intestinal wall and severe impairment of nutrient absorption. The disease primarily affects weanling and yearling horses between three and eight months of age, though cases can occur in horses up to two years old. The condition results in significant protein loss, weight loss, and failure to thrive in affected young horses.

Equine proliferative enteropathy has been recognized worldwide and occurs with increasing frequency as awareness and diagnostic capability have improved. The disease appears on breeding farms, training facilities, and individual properties, with some farms experiencing repeated annual outbreaks in weanling populations. While the true incidence is unknown due to underdiagnosis of mild cases, the condition represents a significant cause of poor growth and weight loss in young horses during the critical post-weaning period. Outbreaks may affect single individuals or multiple animals within a cohort, suggesting environmental contamination and ongoing transmission within affected populations.

The impact of Lawsonia intracellularis infection on young horse health and development can be substantial, as the disease occurs during a critical growth period when nutritional demands are high. Affected weanlings develop protein-losing enteropathy that leads to hypoalbuminemia, edema, weight loss, and poor body condition. Without treatment, severely affected horses may die from complications including secondary infections and organ failure. Even with successful treatment, affected horses may experience growth setbacks that affect long-term development. Performance potential may be impaired if significant muscle wasting occurs during illness before treatment is initiated.

The prognosis for Lawsonia intracellularis infection is generally good when the condition is diagnosed early and appropriate antibiotic therapy is initiated promptly. Most horses respond well to treatment with erythromycin, rifampin, or other effective antibiotics, showing clinical improvement within days and full recovery over several weeks. Early detection is essential because advanced cases with severe hypoproteinemia and complications carry less favorable prognosis. Awareness of this condition among veterinarians and horse owners has improved diagnostic rates, leading to earlier treatment and better outcomes overall. Prevention through good management and potential vaccination helps protect vulnerable weanling populations.

Causes of Lawsonia intracellularis

The primary cause of equine proliferative enteropathy is infection with Lawsonia intracellularis, a curved, gram-negative, obligate intracellular bacterium that cannot survive or replicate outside of host cells. The organism specifically targets the crypt epithelial cells of the small intestine, particularly in the ileum, where it enters cells and multiplies within the cytoplasm. Bacterial replication causes infected cells to proliferate abnormally, resulting in thickening of the intestinal mucosa that characterizes the disease. Transmission occurs through the fecal-oral route, with horses becoming infected by ingesting feed, water, or environmental materials contaminated with feces from infected animals.

No genetic or breed predisposition to Lawsonia intracellularis infection has been identified, as all young horses appear equally susceptible when exposed to the organism. The disease affects Thoroughbreds, Warmbloods, Quarter Horses, and all other breeds without discrimination. However, farms with larger numbers of young horses and those with repeated annual outbreaks may have environmental factors or management practices that facilitate transmission. Individual variation in immune response may influence whether exposed horses develop clinical disease versus subclinical infection that clears without intervention.

Environmental and management factors significantly influence the occurrence and spread of Lawsonia intracellularis on horse farms. The organism is shed in feces of infected horses and can survive in the environment for extended periods under appropriate conditions. Farms with high population density, particularly of weanlings housed together, face elevated outbreak risk. Poor sanitation, overcrowding, and stress associated with weaning may contribute to disease occurrence and severity. The organism has also been identified in swine, which may serve as a reservoir for equine infection on mixed farms or properties near pig operations.

Risk factors for developing clinical disease include age, with horses between three and eight months of age most commonly affected, though cases occur up to two years of age. The weaning period represents particularly high risk, possibly due to stress, dietary changes, and loss of maternal antibodies. Horses new to contaminated premises may be more susceptible than those raised on the property who may have developed partial immunity from low-level exposure. Concurrent disease or stress from transportation, showing, or training may increase susceptibility to clinical disease following exposure.

The disease mechanism involves bacterial invasion of intestinal crypt epithelial cells followed by intracellular replication that drives abnormal cell proliferation. This proliferative response thickens the intestinal wall, particularly affecting the ileum, and impairs normal absorptive function. Protein absorption becomes severely compromised, leading to hypoproteinemia with albumin levels often dropping below critical thresholds. The damaged intestinal mucosa allows protein loss into the gut lumen while failing to absorb dietary protein, creating negative protein balance. Edema develops as oncotic pressure drops from low albumin, and affected horses show ventral, limb, and facial swelling characteristic of hypoproteinemia.

Symptoms & Warning Signs

Early warning signs of Lawsonia intracellularis infection can be subtle and may be attributed to weaning stress or other common problems in young horses. Initial signs often include decreased appetite and reduced interest in feed that owners may interpret as normal adjustment to weaning. Mild depression and decreased activity compared to cohort mates may be noticed by observant caretakers. Growth rate may slow before other clinical signs become apparent, though this is difficult to detect without regular weight monitoring. These early signs are particularly important to recognize because early treatment dramatically improves outcomes.

Common symptoms of established Lawsonia intracellularis infection become more distinctive as the disease progresses. Weight loss is the most consistent finding, with affected weanlings losing condition rapidly despite adequate feed availability. Diarrhea occurs in some but not all cases, and when present may range from soft feces to watery diarrhea. Many affected horses develop edema, with swelling appearing in dependent areas including the ventral abdomen, lower limbs, and sheath or mammary area. Fever is variable and may be mild or absent, making temperature monitoring alone insufficient for disease detection.

Behavioral changes in horses with equine proliferative enteropathy reflect the systemic effects of protein loss and malnutrition. Affected weanlings become increasingly lethargic and may separate from group mates during turnout. Appetite continues to decrease as the disease progresses, with horses showing reduced interest in grain and hay. Some horses develop mild colic signs including pawing, looking at flanks, or lying down more frequently, though severe colic is uncommon. Depression becomes more pronounced with disease progression, and affected horses may stand with lowered head position appearing obviously ill.

Physical signs of Lawsonia intracellularis infection extend beyond the gastrointestinal tract to reflect systemic protein depletion. Peripheral edema is often striking, with swelling of the ventral abdomen creating a pot-bellied appearance in thin weanlings. Limb edema, particularly in the distal legs, may be marked and contribute to stiff movement. Facial or submandibular edema occurs in some cases. Rough, dull hair coat develops as nutritional status declines. Muscle wasting becomes apparent over the topline and hindquarters as protein catabolism occurs. Mucous membranes may appear pale from anemia in some cases.

Symptom progression in untreated Lawsonia intracellularis infection follows a deteriorating course over days to weeks. Initial subtle signs progress to obvious weight loss and edema as protein depletion worsens. Diarrhea, if present, may become more severe or may resolve even as systemic condition worsens. Weakness develops as muscle wasting progresses, and affected horses may have difficulty keeping up with herdmates. Secondary infections may develop as immune function is compromised by malnutrition. Without treatment, severely affected horses may become recumbent and die from complications including sepsis, organ failure, or severe debilitation.

Emergency symptoms requiring immediate veterinary attention include rapid development of severe edema, profuse diarrhea with dehydration, signs of colic or abdominal pain, weakness or difficulty standing, and any signs of sepsis including high fever, rapid heart rate, or injected mucous membranes. Weanlings that show sudden weight loss or failure to thrive warrant prompt evaluation even without dramatic symptoms, as early diagnosis significantly improves treatment success. Any young horse on a property with previous Lawsonia cases that develops decreased appetite or weight loss should be evaluated promptly given the known farm history.

Diagnosis

Physical examination of horses suspected to have Lawsonia intracellularis infection reveals findings consistent with protein-losing enteropathy and poor body condition. Affected weanlings are typically thin with prominent skeletal features despite appropriate feeding. Peripheral edema is commonly present in dependent areas including the ventral abdomen, sheath or udder region, and distal limbs. Gastrointestinal sounds may be increased, decreased, or normal on auscultation. Fever is variable and not consistently present. The combination of weight loss, hypoproteinemia, and edema in a weanling-aged horse strongly suggests equine proliferative enteropathy and warrants specific diagnostic testing.

Diagnostic testing for Lawsonia intracellularis infection includes laboratory evaluation and specific testing for the organism. Complete blood count may reveal anemia, though this is not consistent. Serum chemistry demonstrates the hallmark finding of hypoproteinemia, with total protein often below 4.0 g/dL and albumin frequently below 2.0 g/dL, sometimes dropping to critically low levels of 1.0 g/dL or below. Fibrinogen may be elevated indicating inflammation. Fecal polymerase chain reaction testing for Lawsonia intracellularis DNA provides specific diagnosis and is the most commonly used confirmatory test. Serologic testing for antibodies can support diagnosis but may be negative early in infection before antibody development.

Advanced diagnostic imaging supports the diagnosis of equine proliferative enteropathy by demonstrating characteristic intestinal changes. Abdominal ultrasound reveals thickening of the small intestinal wall, particularly the ileum, which normally measures less than 3mm but may exceed 6-8mm in affected horses. Multiple loops of thickened intestine may be visible. Increased peritoneal fluid may be present as a result of hypoproteinemia. Ultrasound findings combined with clinical signs and laboratory results provide strong presumptive diagnosis while awaiting PCR confirmation. Abdominal radiographs are generally less useful than ultrasound for this condition.

Differential diagnosis for young horses presenting with weight loss, hypoproteinemia, and edema includes several conditions that must be considered. Parasitism, particularly from large strongyles, can cause protein-losing enteropathy in poorly dewormed youngsters. Inflammatory bowel disease may present similarly but is less common in this age group. Salmonellosis and other infectious enteritides can cause diarrhea and weight loss but typically produce more pronounced intestinal signs. Congenital heart defects or other cardiac conditions may cause edema but lack the intestinal component. Chronic hepatic disease causing decreased protein production is possible but rare in young horses. Sand enteropathy in appropriate geographic regions may cause weight loss and diarrhea.

Treatment Options

Emergency treatment for severely affected horses with Lawsonia intracellularis infection addresses life-threatening complications while initiating antibiotic therapy. Horses with profound hypoproteinemia and severe edema may require plasma transfusion to rapidly restore oncotic pressure and prevent complications. Intravenous fluid therapy supports hydration and renal function in horses that have become dehydrated. Critical care monitoring is essential for horses showing signs of sepsis or cardiovascular compromise. Antibiotic therapy should be initiated immediately upon suspicion of disease rather than waiting for diagnostic confirmation, as early treatment dramatically improves outcomes.

Medical management of Lawsonia intracellularis infection centers on antibiotic therapy with agents effective against this intracellular organism. The traditional first-line treatment combines erythromycin and rifampin, administered orally for three to four weeks. Erythromycin is typically dosed at 25 mg/kg three to four times daily, while rifampin is given at 5-10 mg/kg twice daily. This combination penetrates cells effectively and achieves therapeutic levels at the site of infection. Alternative antibiotics include oxytetracycline administered intravenously initially then transitioning to oral doxycycline, chloramphenicol, or azithromycin. Treatment must continue for the full prescribed course to prevent relapse.

Surgical intervention is not applicable to Lawsonia intracellularis infection, as the disease is managed entirely through medical therapy. However, complications that might arise in severe cases could potentially require surgical evaluation. Horses that develop colic signs unresponsive to medical management may require surgical exploration to rule out other conditions or address complications such as intussusception, though this is rare. The primary treatment approach remains antibiotic therapy with supportive care.

Supportive care plays a crucial role in recovery from equine proliferative enteropathy, particularly for horses with significant protein depletion. Nutritional support including high-quality, easily digestible feeds helps provide protein and calories for recovery. Small frequent meals may be better tolerated than large grain portions. Plasma transfusion may be needed in horses with albumin levels below 1.5 g/dL or those showing severe edema and complications. Gastroprotection with omeprazole is often recommended given the duration of antibiotic therapy. Anti-inflammatory medications may help control fever and improve appetite in horses with elevated temperature.

Rehabilitation and return to work following Lawsonia intracellularis infection focuses on restoring body condition and normal growth patterns. Affected weanlings should be allowed to fully recover before resuming normal training schedules, which typically requires several weeks to months depending on severity. Nutritional management emphasizes high-quality protein sources to rebuild muscle mass lost during illness. Regular weight monitoring ensures recovery is progressing appropriately. Many affected horses catch up to cohort mates with time, though severely affected individuals may experience permanent growth setbacks.

Treatment decision factors for Lawsonia intracellularis infection include disease severity, response to initial therapy, and economic considerations. Mild cases may be treated on an outpatient basis with oral antibiotics and monitoring. Severe cases with profound hypoproteinemia, significant edema, or complications require more intensive care including hospitalization and plasma support. The extended duration of antibiotic therapy requires owner commitment and monitoring for adverse effects, particularly diarrhea from erythromycin or right dorsal colitis. Competition horses require attention to drug withdrawal times, which can be extended for some antibiotics used in treatment.

Recovery & Prognosis

Recovery timeline for Lawsonia intracellularis infection varies based on disease severity and treatment timing but typically spans several weeks. Horses treated early in the disease course often show clinical improvement within three to five days of initiating antibiotic therapy, with appetite returning and attitude improving. Protein levels begin to increase within one to two weeks, though normalization may take three to four weeks or longer. Complete resolution of edema follows protein recovery and may take two to four weeks. Full return to normal body condition typically requires one to three months depending on the degree of weight loss experienced before treatment.

Post-treatment care and monitoring following Lawsonia intracellularis infection ensures complete recovery and detects any relapse. Antibiotic therapy must be completed for the full prescribed course, typically three to four weeks, to prevent recurrence. Follow-up blood work at one to two weeks after starting treatment and at treatment completion monitors protein level recovery. Weight should be tracked regularly to confirm appropriate gain. Fecal PCR testing may be performed after treatment completion to confirm clearance of infection, though this is not always necessary in horses showing good clinical response.

Prognosis factors for Lawsonia intracellularis infection strongly favor full recovery when treatment is initiated early and completed appropriately. Horses diagnosed with mild disease and protein levels above 3.5 g/dL generally have excellent prognosis with straightforward recovery. Severe cases with profound hypoproteinemia below 2.0 g/dL, particularly those with albumin below 1.0 g/dL, carry guarded prognosis and may experience complications despite treatment. Development of secondary infections, sepsis, or organ failure significantly worsens prognosis. Compliance with the extended treatment course is essential, as early discontinuation increases relapse risk.

Long-term outlook for horses that recover from Lawsonia intracellularis infection is generally excellent, with most affected horses able to pursue their intended careers without limitation. Growth may be delayed compared to unaffected cohort mates, but catch-up growth typically occurs with appropriate nutrition during recovery. Performance potential is usually not permanently impaired unless severe muscle wasting occurred before treatment. Some farms with repeated outbreaks implement biosecurity changes and vaccination programs to prevent future cases. Recovered horses may have some immunity to reinfection, though the duration and completeness of this protection is not well characterized.

Prevention

Management practices for preventing Lawsonia intracellularis infection focus on reducing pathogen exposure and maintaining young horse health during vulnerable periods. Good sanitation in weanling housing areas reduces environmental contamination with infected feces. Avoiding overcrowding provides adequate space and reduces stress. Gradual weaning practices rather than abrupt separation may reduce stress-related susceptibility. Isolating new arrivals before introduction to resident populations prevents introduction of infection. On farms with previous outbreaks, careful attention to environmental cleanup between weanling groups helps reduce transmission to subsequent cohorts.

Nutritional prevention for Lawsonia intracellularis infection emphasizes maintaining optimal nutritional status to support immune function in weanlings. High-quality, balanced diets appropriate for growing horses provide nutrients needed for normal immune response. Adequate protein intake supports growth without requiring intestinal compensatory mechanisms that stress the gut. Gradual dietary transitions during weaning reduce gastrointestinal stress. Maintaining good body condition in weanlings allows reserves for recovery if disease occurs. Colostrum intake as neonates provides early immune protection, and maintaining mare health supports milk quality during nursing.

Exercise and conditioning considerations for Lawsonia prevention relate to stress reduction rather than direct disease prevention. Gradual introduction of handling, training, and environmental changes reduces stress that may increase disease susceptibility. Avoiding concurrent major stressors such as weaning, transportation, and intensive training simultaneously helps maintain immune function. Young horses should have adequate space for natural exercise and social interaction with appropriate cohort mates. Regular turnout supports overall health and may reduce disease risk compared to confinement.

Environmental factors affecting Lawsonia intracellularis prevention include pasture management and facility hygiene. Rotational grazing may help reduce parasite and bacterial burden on pastures. Proper drainage prevents accumulation of standing water that may harbor pathogens. Cleaning and disinfection of stalls and feeding areas between occupants reduces environmental contamination. On farms where swine are also raised, separation of species and preventing cross-contamination of feed and equipment may reduce transmission, as pigs can carry the organism.

Vaccination programs for Lawsonia intracellularis have become available and show promise for prevention in endemic settings. A modified-live porcine vaccine has been used in horses on some farms with reported reduction in disease incidence, though it is not specifically licensed for equine use. Vaccination of weanlings before anticipated exposure may reduce disease severity and incidence. Vaccination protocols and efficacy continue to be evaluated, and veterinary guidance should be sought for farms considering prophylactic vaccination. Combined with good management practices, vaccination may help control disease on farms with repeated annual outbreaks.

Living With & Managing Lawsonia intracellularis

Daily management adjustments for farms with history of Lawsonia intracellularis focus on early disease detection through close monitoring of weanlings. Daily observation of appetite, attitude, and body condition allows early identification of affected individuals before severe disease develops. Regular weight monitoring, ideally weekly during the high-risk post-weaning period, detects weight loss before it becomes clinically obvious. Monitoring fecal consistency identifies horses with diarrhea for further evaluation. Maintaining consistent daily routines reduces stress for young horses during the vulnerable post-weaning period. Recording observations helps identify subtle changes that might otherwise be overlooked.

Housing and turnout considerations for young horses on farms with Lawsonia risk balance social needs with disease prevention. Group housing provides social interaction important for normal development but may facilitate disease transmission if affected horses are present. Smaller group sizes may reduce outbreak magnitude if disease occurs. Separating age groups prevents older carriers from infecting newly weaned individuals. Providing adequate space per horse reduces stress and fecal contamination of feeding areas. Clean, dry bedding reduces environmental pathogen survival in housing areas.

Exercise modifications for horses recovering from Lawsonia intracellularis infection allow gradual return to normal activity. Rest during acute illness allows energy to be directed toward recovery rather than exercise. As clinical signs resolve and appetite returns, turnout can resume with gradual increase in activity. Avoiding intensive training or showing until fully recovered prevents setbacks. Monitoring for exercise intolerance during recovery indicates whether activity level is appropriate. Most recovered horses can resume normal exercise and training within weeks of completing treatment.

Monitoring and ongoing care on farms with Lawsonia history includes surveillance of at-risk populations and environmental management. Weanling cohorts should be monitored closely from weaning through yearling age. Any clinical signs of disease should prompt immediate evaluation and treatment. Periodic protein level screening of asymptomatic weanlings on high-risk farms may identify subclinical cases for early treatment. Environmental cleanup between weanling groups reduces transmission risk. Veterinary consultation helps develop farm-specific prevention and early detection protocols.

Quality of life and use considerations for horses that have recovered from Lawsonia intracellularis infection are generally excellent. Most affected horses recover fully and can pursue any intended career without limitation. Performance horses may need extended time to regain condition before competition. Breeding stock are not restricted, as the disease is not heritable and recovered horses do not pose ongoing transmission risk once cleared of infection. Farms with endemic problems should consider consulting with specialists to develop comprehensive prevention strategies that improve outcomes for future weanling crops.

Breeds at Risk for Lawsonia intracellularis

All horse breeds are equally susceptible to Lawsonia intracellularis infection, with no genetic predisposition identified in any breed or type. The disease occurs in Thoroughbreds, Warmbloods, Quarter Horses, Arabians, and all other breeds without discrimination. Farm management practices and environmental factors are far more important determinants of disease occurrence than breed characteristics. Breed registries have no specific health testing or certification programs related to Lawsonia risk, as susceptibility is universal and environmental rather than genetic.

Use and discipline considerations for Lawsonia risk relate primarily to management practices on breeding farms rather than intended use of individual horses. Farms producing large numbers of weanlings face higher outbreak potential simply due to population density and the number of susceptible individuals present. Racing and sport horse breeding operations with intensive management may see more cases than small breeding programs. Training and sales consignment operations that congregate young horses from multiple sources face introduction risk. Any discipline may be affected if young horses in that discipline are raised on farms with endemic Lawsonia.

Genetic testing and breeding recommendations specific to Lawsonia intracellularis infection are not applicable, as the disease is not heritable. Breeding decisions need not consider disease history in parents, as susceptibility is determined by environmental exposure rather than genetics. Stallions and mares that have recovered from the disease can be bred normally without concern for offspring health related to this condition. Selection for overall health, immune function, and vigor may indirectly improve resilience to various infectious diseases including Lawsonia.

Related Conditions

Commonly co-occurring conditions with Lawsonia intracellularis infection relate to the gastrointestinal nature of the disease and the age group affected. Parasitism may occur concurrently and should be addressed with appropriate deworming, though heavy parasite burden could also contribute to protein loss and confound diagnosis. Rhodococcus equi pneumonia affects a similar age group and may occur on the same farms, requiring vigilance for respiratory signs in weanlings. Secondary bacterial infections may develop in immunocompromised horses with severe hypoproteinemia. Gastric ulcers are common in weanlings and may be exacerbated by stress of illness and antibiotic treatment.

Conditions with similar symptoms to Lawsonia intracellularis infection require careful differentiation for appropriate treatment. Salmonellosis causes diarrhea and systemic illness in young horses but typically has more pronounced intestinal signs and can be cultured from feces. Clostridial enteritis produces acute, severe diarrhea with rapid deterioration. Parasitism may cause weight loss and hypoproteinemia in heavily infected youngsters but typically shows characteristic egg counts on fecal examination. Inflammatory bowel disease causes malabsorption and protein loss but is less common in young horses. Chronic liver disease causing decreased protein synthesis can produce similar laboratory findings but with additional hepatic indicators.

Potential complications of Lawsonia intracellularis infection include several serious conditions that may develop in severe or untreated cases. Profound hypoproteinemia can lead to body cavity effusions, impaired wound healing, and increased susceptibility to secondary infections. Sepsis may develop as bacterial translocation occurs through the damaged intestinal barrier. Thrombophlebitis may occur with prolonged intravenous catheterization during treatment. Adverse reactions to antibiotics, particularly erythromycin-associated diarrhea and colitis, complicate treatment in some cases. Right dorsal colitis is a recognized complication of nonsteroidal anti-inflammatory drug use in horses with compromised gastrointestinal health.